The rates in increasing susceptibility of MRSA with antibiotics were 2 - 4 fold in these cases. These findings suggested that 2-salicyloylbenzofuran bearing carboxylic acid derivatives could potentially be used as antibiotic enhancers to the activity of existing antibiotics against MRSA.